-
Most popular investments: What did private investors buy in October?Money market funds continued their upbeat streak as investors sought stability in a volatile world, while space-themed funds and stocks remained popular.
-
“Follow the Money”: Stephen Yiu’s strategy for the AI eraFollowing the money across the three sources of spending – consumer, business, and government – Blue Whale Growth Fund manager Stephen Yiu shares his strategy.
-
The IPO catch: Why the best deals are often the hardest to buy intoUK investors can now apply for the biggest US flotations. Miss out and buy once trading starts, and history suggests you'll do no better than the market, while carrying one company's risk.
-
Tech selloff: are AI spending concerns justified?Investors are growing increasingly anxious about AI spending amid the hyperscalers, as disappointing earnings reports wipe trillions of dollars off market values.
-
Is it still worth being a landlord after the Budget?Landlords were targeted again in the Autumn Budget with further tax hikes. Is buy-to-let still worth it?
-
Two alternative income fundsThese income funds in the specialist debt sector are stablemates, but offer very different options for investors looking for yield
-
Three top-class smaller biotechnology companiesOpinion Three smaller biotechnology companies with big potential, picked by Geoffrey Hsu, managing partner at OrbiMed and portfolio manager of the Biotech Growth Trust.
Opinion -
Diamonds have lost their lustre – are they worth buying?The diamond industry is at a crossroads, with laboratory-grown diamonds further diminishing the gemstone's appeal. Are they no longer an investor's best friend?
-
The extraordinary rise of Sea Limited, Asia's online marketplaceAsian online shopping company Sea Limited is well placed to recover from recent disasters. Is it time to buy its shares?
